Clinical Trial Update: The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating cholinergic receptor block therapy for safety and effectiveness in amyotrophic lateral sclerosis with respiratory function consi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Ruijin Hospital | Conditions: Amyotrophic Lateral Sclerosis, Respiratory Function | Phase 2 | Status: UNKNOWN